ATHA
Price
$1.97
Change
+$0.10 (+5.35%)
Updated
Dec 8, 6:59 PM EST
102 days until earnings call
EDIT
Price
$10.51
Change
-$0.39 (-3.58%)
Updated
Dec 8, 6:59 PM EST
74 days until earnings call
Ad is loading...

ATHA vs EDIT ᐉ Comparison: Which is Better to Invest?

Header iconATHA vs EDIT Comparison
Open Charts ATHA vs EDITBanner chart's image
Athira Pharma
Price$1.97
Change+$0.10 (+5.35%)
Volume$191.63K
CapitalizationN/A
Editas Medicine
Price$10.51
Change-$0.39 (-3.58%)
Volume$1.67M
CapitalizationN/A
View a ticker or compare two or three
ATHA vs EDIT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ATHA vs. EDIT commentary
Dec 10, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Buy and EDIT is a Hold.

COMPARISON
Comparison
Dec 10, 2023
Stock price -- (ATHA: $1.97 vs. EDIT: $10.51)
Brand notoriety: ATHA and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 141% vs. EDIT: 155%
Market capitalization -- ATHA: $58.22M vs. EDIT: $870.23M
ATHA [@Biotechnology] is valued at $58.22M. EDIT’s [@Biotechnology] market capitalization is $870.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • ATHA’s TA Score: 5 bullish, 4 bearish.
  • EDIT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than EDIT.

Price Growth

ATHA (@Biotechnology) experienced а +30.46% price change this week, while EDIT (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

ATHA is expected to report earnings on Mar 21, 2024.

EDIT is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATHA with price predictions.
OPEN
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EDIT($870M) has a higher market cap than ATHA($58.2M). EDIT YTD gains are higher at: 18.489 vs. ATHA (-37.855). ATHA has higher annual earnings (EBITDA): -117.03M vs. EDIT (-202.49M). EDIT has more cash in the bank: 350M vs. ATHA (173M). ATHA has less debt than EDIT: ATHA (1.67M) vs EDIT (34.6M). EDIT has higher revenues than ATHA: EDIT (24.6M) vs ATHA (0).
ATHAEDITATHA / EDIT
Capitalization58.2M870M7%
EBITDA-117.03M-202.49M58%
Gain YTD-37.85518.489-205%
P/E RatioN/AN/A-
Revenue024.6M-
Total Cash173M350M49%
Total Debt1.67M34.6M5%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAEDIT
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASHTY256.717.27
+2.91%
Ashtead Group Plc
PACK4.720.11
+2.39%
Ranpak Holdings Corp
VDMCY5.16-0.06
-1.15%
Vodacom Group Ltd
LUGDF11.89-0.46
-3.72%
Lundin Gold
VYNE2.99-0.25
-7.72%
VYNE Therapeutics

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with CRSP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+5.35%
CRSP - ATHA
38%
Loosely correlated
-8.08%
AGIO - ATHA
36%
Loosely correlated
-4.71%
OCUL - ATHA
36%
Loosely correlated
-2.69%
NUVB - ATHA
36%
Loosely correlated
+3.10%
ALNY - ATHA
35%
Loosely correlated
-4.07%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with BEAM. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-3.58%
BEAM - EDIT
70%
Closely correlated
-8.17%
NTLA - EDIT
68%
Closely correlated
-2.55%
CRSP - EDIT
65%
Loosely correlated
-8.08%
MDGL - EDIT
61%
Loosely correlated
-11.58%
DNLI - EDIT
59%
Loosely correlated
-1.97%
More